Arrhythmia Research Technology, Inc. (AMEX:HRT)

CAPS Rating: No stars

The Company is engaged in the development and licensing of medical software, which acquires data and analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias.

No players have picked HRT yet. Tell us why you think HRT will outperform or underperform the market.

Featured Broker Partners


Advertisement